New device may simplify ECMO removal, reduce bleeding risks
NCT ID NCT07019662
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a special suture device (Perclose ProStyle) can close the artery as safely as standard methods (manual pressure or surgery) after removing ECMO tubes in patients with severe heart and lung failure. About 102 adults on VA-ECMO will be randomly assigned to the device or standard care. The goal is to see if the device reduces complications like bleeding, blood clots, or vessel injury.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Abbott Perclose™ ProStyle™ Suture-Mediated Closure System
- What this could lead to
- If successful, this could provide a less invasive, safer way to close arteries after ECMO removal, reducing bleeding and recovery time.
- What could go wrong
- This is a relatively small, early-stage trial (102 participants) comparing a device to varied standard practices, so results may not apply broadly. Device failure could cause bleeding or vessel injury.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VA-ECMO are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Universitäres Herz- und Gefäßzentrum Frankfurt ZIM - Med. Clinic 3 - Cardiology and Angiology
RECRUITINGFrankfurt, Germany
-
Universitätsmedizin der Johannes Gutenberg-Universität Mainz - Zentrum für Kardiologie
RECRUITINGMainz, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.